Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Association of depth of target lesion response to brigatinib with outcomes in patients with ALK inhibitor-naive ALK plus NSCLC in ALTA-1L.
- Authors
- Camidge, DR[Camidge, D. Ross]; Kim, HR[Kim, Hye Ryun]; Ahn, MJ[Ahn, Myung-Ju]; Yang, JC[Yang, James Chih-Hsin]; Han, JY[Han, Ji-Youn]; Hochmair, M[Hochmair, Maximilian]; Lee, KH[Lee, Ki Hyeong]; Delmonte, A[Delmonte, Angelo]; Campelo, RG[Garcia Campelo, Rosario]; Kim, DW[Kim, Dong-Wan]; Griesinger, F[Griesinger, Frank]; Felip, E[Felip, Enriqueta]; Califano, R[Califano, Raffaele]; Spira, AI[Spira, Alexander I.]; Thomas, M[Thomas, Michael]; Gettinger, SN[Gettinger, Scott N.]; Tiseo, M[Tiseo, Marcello]; Liu, YY[Liu, Yuyin]; Zhang, PK[Zhang, Pingkuan]; Popat, S[Popat, Sanjay]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.